Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis.

We report 10 candidates with optimal binding features to the active site of the protease for further consideration as potential drugs to treat patients infected with the emerging COVID-19 disease. PMID: 32773989 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32773989?dopt=Abstract

Source: Bioinformation - August 13, 2020 Category: Bioinformatics Authors: Hakmi M, Bouricha EM, Kandoussi I, Harti JE, Ibrahimi A Tags: Bioinformation Source Type: research